Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers
Authors:
G. Chenevix-Trench, O. M. Sinilnikova, G. Suthers, N. Pandeya, S. Mazoyer, J. F. Sambrook, S. Goldup, D. Goldgar, H. T. Lynch, G. M. Lenoir, G. Cheetham, kConFab
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.